Elevated neurofilament levels in neurological diseasesNiklas Norgren, Torgny Stigbrand, Lars Rosengren|Brain Research|2003Cited by 355
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumabMartin Gunnarsson, Jan Lycke, Lars Rosengren et al.|Annals of Neurology|2010Cited by 347
Neurofilament and glial fibrillary acidic protein in multiple sclerosisNiklas Norgren, Martin Gunnarsson, Peter Sundström et al.|Neurology|2004Cited by 245
Neurofilament ELISA validationAxel Petzold, George P. Paraskevas, Ayşe Altıntaş et al.|Journal of Immunological Methods|2009Cited by 105
Monoclonal Antibodies Selective for Low Molecular Weight NeurofilamentsNiklas Norgren, Torgny Stigbrand, Jan‐Erik Karlsson et al.|Hybridoma and Hybridomics|2002Cited by 84